BIOCAD
About Us
Global presence
Mission & Values
Facilities
Sustainability
Career
R&D
Technological platforms
Clinical Trials
Scientific Publications
Products
Theurapeutic Areas
Products
Partnering
Media
News
Press Kit
Contacts
RU
Products
Our portfolio includes more than 60 products; more than 20 of them are biological. Here you may find the list of BIOCAD’s bestselling products, which we are already exporting or are ready to export in the near future.
Acellbia® (rituximab)
Avegra® (bevacizumab)
Herticad® (trastuzumab)
Prolgolimab
Levilimab
Netakimab
Eculizumab
We have over 60 products.
To see more products which are marketed in Russia and CIS countries go to
biocad.ru
(only in Russian)